DRKS00004611已完成未知
Clinical and radiographic evaluation of short implants placed in the posterior mandible: A 2-year prospective cohort split-mouth study - DSI Study
Dentium0 个研究点目标入组 10 人开始时间: 2013年1月28日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomized controlled study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 70 Years（—）
- 性别
- All
入选标准
- •1.Ability to understand the nature of the study and related procedures.
- •2.Written informed consent obtained according to the international guidelines and local law regulations.
- •3.The subject must be in the age between 18 and 70 years.
- •4.The subject must be systemically healthy and have good compliance.
- •5.The subject must have stable occlusal relationship with no pronounced parafunction such as bruxism.
- •6.The subject must be missing contralaterally the lower bicuspids or the second bicuspid and the first lower molar, and in need of bilateral implant-supported restorations in the posterior mandible.
- •7.The implant site must be free from infection and/or extraction remnants.
- •8.The subjects must have sufficient bone volume and density i.e. an osseous architecture in the implant region enough to accommodate implants of Ø 4 mm and a sufficient amount of bone for placing two implants with a length of at least 7 mm on one side of the posterior mandible and with a length of at least 10 mm on the contralateral side.
- •9.The osseous structure must allow for primary stability of the placed implant, i.e. final tightening torque of 35-45 Ncm.
排除标准
- •1.Alcohol or drug abuse as noted in patient records or in patient history.
- •3.Health conditions the do not allow for surgical procedures.
- •4.Reason to believe that the treatment might have a negative effect on the subject’s general situation (psychiatric conditions), as noted in patient records or in patient history.
- •5.The patient has an infectious disease, heart disease or disease of the circulatory system, metabolic disease, bone metabolism disorders, disturbance of the hematopoietic system, hematological disorders, wound healing disturbances, disorders of the endocrine system (i.e., uncontrolled diabetes), pregnancy, local (i.e. tumors, ulcers, etc.) or other contraindications for dental surgery as noted in patient records or in patient history.
- •6.The subject is not able to give his/her informed consent to participate.
- •7.The need of bone augmentation.
- •8.Any disorders in the planned implant area such as previous tumors, chronic bone disease or previous radiotherapy.
- •9.Severe bruxism or other destructive disease.
- •10.Immediate implant placement (e.g. placement of the implant immediately after tooth extraction).
- •11.Intake of a medication that is known to interfere with the objectives of the study and/or is contraindication of the surgical procedure within 2 weeks prior to entry into the study.
- •12.Intake of investigational drugs less than 30 days prior to entry into the study.
- •13.Female patients who are pregnant or breast feeding, or female patients of reproductive potential not employing an effective method of birth control (postmenopausal state at least since 2 years, surgically sterile, hysterectomy or effective contraceptive method until delivery of the final prosthetic restoration.
- •In female patients with a reproductive potential, implant placement will only be performed if a negative urine pregnancy test result dated 3-14 days prior to implantation is documented. Women have to be advised that they must not become pregnant until delivery of the final restorations has taken place.
研究者
相似试验
招募中
不适用
Clinical and Radiographic evaluation of short implants (5.5mm) and standard implants (10MM) with internal sinus floor elevation in posterior maxillaPACTR201603001536183mostafa magdy awad50
已完成
不适用
Clinical and Radiographic Evaluations of Restorations in Dentin Surface of Molars DeciduousDental caries.C07.793.720.210RBR-5h8853niversidade Federal do Rio Grande do Sul
尚未招募
3 期
A clinical trial to assess the effect of change in bone levels following implant placement immediately after removal of tooth with and without socket shield (leaving a tooth root section)CTRI/2018/06/014610Divya Das
已完成
3 期
mineral trioxide aggregate(MTA), calcium-enriched mixture (CEM) cement and Calcium hydroxide in pulpotomized primary molar with laserprimary molar pulpotomy.IRCT20200328046884N1Shahed University30
尚未招募
不适用
A prospective clinical and radiological study of incidental cerebral small vessel disease: Aspirin versus Cilostazol (PACCS)Nervous System DiseasesPACTR202301861240705Hany Aref220